Validation of a simplified international prognostic score (IPS‐3) in patients with advanced‐stage classic Hodgkin lymphoma

Summary A novel prognostic score (IPS‐3), comprised of only three of the seven IPS‐7 indicators (age ≥45, stage IV, haemoglobin

Saved in:
Bibliographic Details
Published in:British journal of haematology 2020-04, Vol.189 (1), p.122-127
Main Authors: Hayden, Anna R., Lee, Derrick G., Villa, Diego, Gerrie, Alina S., Scott, David W., Slack, Graham W., Sehn, Laurie H., Connors, Joseph M., Savage, Kerry J.
Format: Article
Language:English
Subjects:
ABVD
Adolescent
Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols - administration & dosage
Bleomycin
Bleomycin - administration & dosage
British Columbia - epidemiology
Dacarbazine
Dacarbazine - administration & dosage
Disease-Free Survival
Doxorubicin
Doxorubicin - administration & dosage
Female
Hematology
Hemoglobin
Hodgkin Disease - drug therapy
Hodgkin Disease - mortality
Hodgkin's lymphoma
hodgkins lymphoma
Humans
international prognostic score
Lymphoma
Male
Middle Aged
Predictive Value of Tests
prognostic factors
Survival Rate
Vinblastine
Vinblastine - administration & dosage
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Summary A novel prognostic score (IPS‐3), comprised of only three of the seven IPS‐7 indicators (age ≥45, stage IV, haemoglobin
ISSN:0007-1048
1365-2141
DOI:10.1111/bjh.16293